Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/007570 stock hub

KRX/007570 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/007570is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

185.3B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/007570

In the news

Latest news · KRX/007570

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E27.6

P25 12P50 23.1P75 39.5

ROE3

P25 -17.1P50 0.7P75 8.5

ROIC0.8

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/007570 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

KRW

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	666
Enterprise value	KRW 287.4B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7007570005
Last refreshed	2026-05-10
Market cap	KRW 185.3B
Price	KRW 10,340
Price currency	KRW
Rev Per Employee	409,042,359.91x
Sector	Healthcare
Sic	2834
Symbol	krx/007570
Website	https://home.ilyang.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.73%
EV Earnings	41.63x
EV/EBIT	69.79x
EV/EBITDA	23.06x
EV/FCF	45.46x
EV/Sales	1.06x
FCF yield	3.41%
P/B ratio	0.77x
P/E ratio	27.57x
P/S ratio	0.68x
PE Ratio10 Y	94.08x
PE Ratio3 Y	66.42x
PE Ratio5 Y	53.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.82%
EBITDA Margin	4.88%
FCF margin	2.32%
Gross margin	42.68%
Gross Profit	KRW 116.3B
Gross Profit Growth	4.55%
Gross Profit Growth Q	8.63%
Gross Profit Growth3 Y	2.43%
Gross Profit Growth5 Y	-8.53%
Net Income	KRW 6.9B
Net Income Growth	-23.55%
Net Income Growth Years	0%
Net Income Growth3 Y	-28.55%
Net Income Growth5 Y	-8.69%
Pretax Margin	4.87%
Profit Margin	2.53%
Profit Per Employee	KRW 10.4M
Profitable Years	2
ROA	0.7
Roa5y	1.82
ROCE	1.73
ROE	2.97
Roe5y	4.17
ROIC	0.77
Roic5y	3.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-12.91%
Cagr15y	-2.9%
Cagr1y	-14.86%
Cagr20y	-1.71%
Cagr3y	-15.29%
Cagr5y	-21.63%
Div CAGR10	4.48%
Div CAGR3	1.1%
Div CAGR5	-4.97%
EPS Growth	-23.47
EPS Growth Years	0
EPS Growth3 Y	-28.93
EPS Growth5 Y	-8.88
FCF Growth3 Y	48.33%
FCF Growth5 Y	-33.14%
OCF Growth	114.44%
OCF Growth Q	-14.86%
OCF Growth10 Y	-4.27%
OCF Growth3 Y	26.96%
OCF Growth5 Y	-26.85%
Revenue Growth	1.39x
Revenue Growth Q	-4.23x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	3.21x
Revenue Growth5 Y	-4.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.61
Assets	KRW 457.3B
Cash	KRW 29.6B
Current Assets	KRW 147.8B
Current Liabilities	KRW 171.2B
Debt	KRW 126.8B
Debt EBITDA	KRW 9.53
Debt Equity	KRW 0.53
Debt FCF	KRW 20.05
Equity	KRW 241.4B
Interest Coverage	1.64
Liabilities	KRW 215.9B
Long Term Assets	KRW 309.6B
Long Term Liabilities	KRW 44.7B
Net Cash	KRW -97.2B
Net Cash By Market Cap	KRW -52.43
Net Debt EBITDA	KRW 7.3
Net Debt Equity	KRW 0.4
Net Debt FCF	KRW 15.37
Tangible Book Value	KRW 234.8B
Tangible Book Value Per Share	KRW 11,865
WACC	4.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.86
Inventory Turnover	2.52
Net Working Capital	KRW 46.7B
Quick ratio	0.46
Working Capital	KRW -23.4B
Working Capital Turnover	KRW -9.77

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.11%
Dividend Growth	3.33%
Dividend Growth Years	1%
Dividend per share	KRW 155
Dividend Years	7
Dividend Yield	1.5%
Ex Div Date	2025-12-29
Last Dividend	KRW 155
Payout Frequency	Annual
Payout Ratio	41.72%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-74.88%
1Y total return	-14.86%
200-day SMA	12,161.7
3Y total return	-39.22%
50-day SMA	12,092
50-day SMA vs 200-day SMA	50under200
5Y total return	-70.42%
All Time High	106,500
All Time High Change	-90.29%
All Time High Date	2020-07-21
All Time Low	1,415
All Time Low Change	630.74%
All Time Low Date	2004-06-23
ATR	465
Beta	0.55
Beta1y	-0.08
Beta2y	0.12
Ch YTD	-20.77
High	10,600
High52	16,240
High52 Date	2026-03-26
High52ch	-36.33%
Low	10,280
Low52	10,280
Low52 Date	2026-05-08
Low52ch	0.58%
Ma50ch	-14.49%
Price vs 200-day SMA	-14.98%
RSI	27.69
RSI Monthly	36.22
RSI Weekly	32.38
Sharpe ratio	-0.45x
Sortino ratio	-0.52
Total Return	1.61%
Tr YTD	-19.81
Tr15y	-35.74%
Tr1m	-16.14%
Tr1w	-6%
Tr3m	-19.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 5B
Operating Income Growth	-48.43
Operating Income Growth Q	-72.84
Operating Income Growth3 Y	-29.64
Operating Income Growth5 Y	-31.99
Operating margin	1.82

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,728,247%
Net Borrowing	18,469,365,350
Shares Insiders	28.98%
Shares Institutions	3.85%
Shares Out	17,924,965
Shares Qo Q	7.41%
Shares Yo Y	-0.11%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 6.3B
Average Volume	91,626.15x
Bv Per Share	11,951.6
CAPEX	KRW -5.7B
Ch10y	-76.34
Ch15y	-39.88
Ch1m	-16.14
Ch1w	-6
Ch1y	-15.87
Ch20y	-37.52
Ch3m	-20.77
Ch3y	-41.32
Ch5y	-71.86
Ch6m	-20.77
Change	-0.19%
Change From Open	-0.19
Close	10,360
Days Gap	0
Depreciation Amortization	8,343,950,330
Dollar Volume	623,832,880
Earnings Date	2026-05-13
EBIT	KRW 5B
EBITDA	KRW 13.3B
EPS	KRW 375
F Score	6
FCF	KRW 6.3B
FCF EV Yield	2.2x
FCF Per Share	KRW 353
Financing CF	14,617,455,370
Fiscal Year End	December
Founded	1,946
Graham Number	10041.97692
Graham Upside	-2.88
Income Tax	KRW 6.1B
Investing CF	-7,225,222,910
Is Primary Listing	1
Last Earnings Date	2026-02-13
Last Report Date	2025-12-31
Last Split Date	2006-06-26
Last Split Type	Forward
Lynch Fair Value	KRW 1,875
Lynch Upside	-81.87
Ma150	12,412.9
Ma150ch	-16.7%
Ma20	11,427
Ma20ch	-9.51%
Net CF	19,358,555,670
Next Earnings Date	2026-05-13
Open	10,360
P FCF Ratio	29.31
P OCF Ratio	15.39
Payment Date	2026-04-24
Position In Range	18.75
Ppne	220,675,336,340
Price Date	2026-05-08
Price EBITDA	KRW 13.93
Ptbv Ratio	0.79
Relative Volume	0.66x
Revenue	272,422,211,700x
Tax By Revenue	2.25x
Tax Rate	46.21%
Tr20y	-29.11%
Tr6m	-19.81%
Volume	60,332
Z Score	1.56

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/007570 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.5%

$155 annual per share

Payout ratio

+41.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-5.0%

1 consecutive years of growth

Total shareholder yield

+1.6%

Next ex-dividend date: 2025-12-29

Performance

KRX/007570 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/007570?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.9%

Share of float held by funds and institutions

Insider ownership

+29.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

KRX/007570 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

27.7

Below 30: short-term oversold

Price vs 200-day MA

-15.0%

50/200-day relationship not available

Beta (5Y)

0.55

Less volatile than the market

Sharpe ratio

-0.45

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/007570

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/007570 stock rating?

krx/007570 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/007570 analysis?

The full report lives at /stocks/krx/007570/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/007570?

The latest report frames krx/007570 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/007570 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.